Exercise for aromatase-inhibitor joint pain after breast cancer

Evidence label: Positive randomized symptom-support evidence · Clinical goal: reduce aromatase-inhibitor–associated joint pain

Evidence at a glance

Population: 121 previously inactive postmenopausal breast-cancer survivors taking an aromatase inhibitor and reporting arthralgia.
Intervention: a yearlong program targeting 150 minutes per week of moderate aerobic exercise plus supervised strength training twice weekly.
Result: worst joint-pain scores fell by 1.6 points in the exercise group and rose by 0.2 points with usual care.

What was studied

The HOPE trial randomized 121 women to exercise or usual care for 12 months. The primary symptom outcome was worst joint pain on the Brief Pain Inventory; other validated pain, stiffness and upper-limb function measures were also collected.

What the evidence shows

At 12 months, worst joint pain decreased 29% with exercise and increased 3% with usual care (between-group P<.001). Improvements were also reported for pain severity and interference. This supports a structured exercise option for symptom management; it does not show that exercise substitutes for endocrine therapy.

This is supportive-care evidence. Pain relief does not establish improved tumor response, recurrence prevention or survival.

Limits and uncertainty

Participants were inactive at baseline, the intervention required sustained training and adherence varied. The comparison was not blinded, and a 1.6-point average reduction may not feel equally important to every patient. The study was publicly and nonprofit funded; investigator disclosures should be read in the full report.

Safety and practical context

Joint pain may also reflect arthritis, injury, bone metastasis or fracture risk. New focal bone pain, weakness, swelling or pain that rapidly worsens needs clinical assessment before increasing load. Exercise should be adapted rather than used as a reason to stop an aromatase inhibitor without oncology input.

Questions for the care team

Could another cause of my joint pain need evaluation?
What aerobic and resistance starting level fits my current function and bone health?
How will we judge whether the symptom benefit is enough to support treatment adherence?

Sources

Literature searched: October 22, 2026 · Record appraised: October 22, 2026

Educational evidence summary, not personal medical advice. Research regimens describe what was studied; they are not personal prescribing instructions and should not replace cancer treatment or individualized supportive care.

Related Missing Script review

Exercise for Aromatase-Inhibitor Joint Pain: A Helpful Option, Not a Guaranteed Fix